GlassScriptPhysician profile
Gerald E Niernberger
NPI 1417986894
$602.76
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $30.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $110.00 | 2019 | |
| Amgen INC. | $87.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.49 | 2019 | |
| Novo Nordisk INC | $50.10 | 2019 | |
| Allergan, INC. | $43.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.00 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.84 | 2019 | |
| Lilly USA, LLC | $27.69 | 2019 | |
| Astellas Pharma US INC | $26.85 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.48 | 2019 | |
| Radius Health, INC. | $17.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.71 | 2019 | |
| Tris Pharma INC | $14.28 | 2019 | |
| Shire North American Group INC | $14.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.60 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.34 | 2019 | |
| Merck Sharp & Dohme LLC | $11.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Niernberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.